A novel GSK3β inhibitor ameliorates tau aggregation and neuroinflammation in Alzheimer's disease
{{output}}
In Alzheimer's disease, increased GSK3β activity drives tau phosphorylation and directly or indirectly triggers neuroinflammation, neuronal damage and cognitive decline. We previously developed a novel GSK3β inhibitor, ZLWH-60, which demonstrated inhibitory... ...
